The present invention relates to the treatment of osteoarthritis and pain using IL-1α and IL-1&bgr; binding proteins, including anti-IL-1α and anti-IL-1&bgr; antibodies and engineered multivalent and multispecific IL-1α and IL-1&bgr; binding proteins.